| Company/Division name | Hitachi Chemical Advanced Therapeutic Solutions |
| Parent company | Hitachi Chemical Company, Ltd. |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2020 |
| Country(ies) from which reshored: | Japan |
| City reshored to: | Allendale |
| State(s) reshored to: | NJ |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | cell and gene therapy products |
| What domestic positive factors made reshoring more attractive? | Automation/technology, Customer responsiveness improvement, Proximity to customers/market, Other, partnership |
